Lysosomal Acid Lipase Deficiency in Risk Groups
ConditionLysosomal Acid Lipase Deficiency
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAstraZeneca
About this trial
A multicenter real-world observational study of the prevalence, diagnostic pathways, and clinical characteristics of lysosomal acid lipase deficiency in pediatric and adolescent risk groups in the Russian Federation (HELIOS)
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
4Research site Nizhny Novgorod Russia
Research Site Petrozavodsk Russia
Research Site Rostov-on-Don Russia
Research Site Saint Petersburg Russia
Sponsors and collaborators
AstraZeneca
Lead sponsor
Source ClinicalTrials.gov